QuintilesIMS is now IQVIA

On November 6, 2017, QuintilesIMS (NYSE:Q) announced that it will be changing its name to IQVIA, a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. We congratulate our parent company on this important … Read More

Quintiles Completes Acquisition of Novella Clinical

RESEARCH TRIANGLE PARK, NC – September 16, 2013 – Quintiles today announced that it has completed the previously announced acquisition of Novella Clinical (Novella), a full-service clinical research organization (CRO) focused primarily on emerging oncology customers as well as those … Read More

Novella Clinical Announces New Leadership Roles

RESEARCH TRIANGLE PARK, N.C., September 3, 2013 – Novella Clinical, a full service clinical research organization, today announced three senior executives have assumed new leadership roles within the organization. Deborah Turunjian has been named Vice President, Oncology Clinical Development and … Read More

Quintiles to Acquire Novella Clinical

RESEARCH TRIANGLE PARK, NC, August 14, 2013   Novella Clinical to Become Standalone Unit in Quintiles’ Clinical Development Group “We are extremely excited about the opportunity to join Quintiles – the global leader in our industry,” said Richard Staub, President and CEO … Read More